Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: Results of three sequential pilot studies

Stem Cell Research and Therapy

Volumn 4, Issue 2, 2013, Pages

  Quimby, Jessica M ^a   Webb, Tracy L ^a   Habenicht, Lauren M ^a   Dow, Steven W ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Cell culture; Cytokines; Feline; Kidney; Mesenchymal stem cells; Urine

Indexed keywords

CREATININE; CYTOKINE; MEMBRANE ANTIGEN;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BREATHING DISORDER; CAT; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYOPRESERVATION; GLOMERULUS FILTRATION RATE; INTRAVENOUS ADMINISTRATION; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SAFETY; URINALYSIS; VOMITING; ADIPOSE TISSUE; ALLOTRANSPLANTATION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; URINE;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, SURFACE; CATS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CRYOPRESERVATION; CYTOKINES; GLOMERULAR FILTRATION RATE; INFUSIONS, INTRAVENOUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PILOT PROJECTS; RENAL INSUFFICIENCY, CHRONIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84877769576     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt198     Document Type: Article

References (40)

1. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). DiBartola SP, Rutgers HC, Zack PM, Tarr MJ, J Am Vet Med Assoc 1987 190 1196 1202 3583899
2. Histomorphometry of feline chronic kidney disease and correlation with markers of renal dysfunction. Chakrabarti S, Syme HM, Brown CA, Elliott J, Vet Pathol 2013 50 147 155 10.1177/0300985812453176 22773469
3. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Lee SR, Lee SH, Moon JY, Park JY, Lee D, Lim SJ, Jeong KH, Park JK, Lee TW, Ihm CG, Ren Fail 2010 32 840 848 10.3109/0886022X.2010.494803 20662698
4. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria- Avancini-Costa-Malheiros D, Antonia-dos-Reis M, Shimizu MH, Seguro AC, Pacheco-Silva A, Saraiva-Camara NO, Stem Cells 2009 27 3063 3073 19750536
5. Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model. Villanueva S, Ewertz E, Carrión F, Tapia A, Vergara C, Céspedes C, Sáez PJ, Luz P, Irarrázabal C, Carreño JE, Figueroa F, Vio CP, Clin Sci (Lond) 2011 121 489 499 10.1042/CS20110108
6. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Ninichuk V, Gross O, Segerer S, Hoffmann R, Radomska E, Buchstaller A, Huss R, Akis N, Schlondorff D, Anders HJ, Kidney Int 2006 70 121 129 10.1038/sj.ki.5001521 16723981 (Pubitemid 44000128)
7. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Cavaglieri RC, Martini D, Sogayar MC, Noronha IL, Transplant Proc 2009 41 947 951 10.1016/j. transproceed.2009.01.072 19376395
8. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G, J Am Soc Nephrol 2004 15 1794 1804 10.1097/01.ASN.0000128974.07460.34 15213267 (Pubitemid 38822058)
9. Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. Kitamura S, Yamasaki Y, Kinomura M, Sugaya T, Sugiyama H, Maeshima Y, Makino H, FASEB J 2005 19 1789 1797 10.1096/fj.05-3942com 16260649 (Pubitemid 41598763)
10. Improvement of kidney failure with fetal kidney precursor cell transplantation. Kim SS, Park HJ, Han J, Gwak SJ, Park MH, Song KW, Rhee YH, Min-Chung H, Kim BS, Transplantation 2007 83 1249 1258 10.1097/01.tp.0000261712. 93299.a6 17496543 (Pubitemid 46743688)
11. Review article: potential cellular therapies for renal disease: can we translate results from animal studies to the human condition? Little MH, Rae FK, Nephrology (Carlton) 2009 14 544 553 10.1111/j.1440-1797.2009.01144.x
12. The use of stem cells in kidney disease. Chhabra P, Brayman KL, Curr Opin Organ Transplant 2009 14 72 78 10.1097/MOT.0b013e328320d2f5 19337150
13. Mesenchymal stem cell therapy for chronic renal failure. Choi SJ, Kim JK, Hwang SD, Expert Opin Biol Ther 2010 10 1217 1226 10.1517/14712598.2010.500284 20560782
14. Therapeutic applications of mesenchymal stem cells to repair kidney injury. Asanuma H, Meldrum DR, Meldrum KK, J Urol 2010 184 26 33 10.1016/j.juro.2010.03.050 20478602
15. Stem cell therapy and regenerative medicine. O'Brien T, Barry FP, Mayo Clin Proc 2009 84 859 861 10.4065/84.10.859 19797773
16. Stem cells and the kidney: a new therapeutic tool? Zerbini G, Piemonti L, Maestroni A, Dell'Antonio G, Bianchi G, J Am Soc Nephrol 2006 17 123 126 10.1681/ASN.2005121339 16565235
17. Stem cell therapy for the kidney? Zubko R, Frishman W, Am J Ther 2009 16 247 256 10.1097/MJT.0b013e3181800591 19092639
18. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Reinders ME, Fibbe WE, Rabelink TJ, Nephrol Dial Transplant 2010 25 17 24 10.1093/ndt/gfp552 19861311
19. Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in mice. Deak E, Ruster B, Keller L, Eckert K, Fichtner I, Seifried E, Henschler R, Cytotherapy 2010 12 260 264 10.3109/14653240903401840 19929457
20. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C, Am J Physiol Renal Physiol 2005 289 31 42 10.1152/ajprenal.00007.2005 15713913 (Pubitemid 40863570)
21. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. Quimby JM, Webb TL, Gibbons DS, Dow SW, J Feline Med Surg 2011 13 418 426 10.1016/j.jfms.2011.01.005 21334237
22. In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells. Webb TL, Quimby JM, Dow SW, J Feline Med Surg 2012 14 165 168 10.1177/1098612X11429224 22314096
23. Adipose-derived mesenchymal stem cells: biology and potential applications. Minteer D, Marra KG, Rubin JP, Adv Biochem Eng Biotechnol 2013 129 59 71 22825719
24. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. Castelo-Branco MT, Soares ID, Lopes DV, Buongusto F, Martinusso CA, do-Rosario A, Souza SA, Gutfilen B, Fonseca LM, Elia C, Madi K, Schanaider A, Rossi MI, Souza HS, PLoS One 2012 7 33360 10.1371/journal.pone.0033360 22432015
25. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, Blancher A, Br J Haematol 2005 129 118 129 10.1111/j.1365-2141.2005.05409.x 15801964 (Pubitemid 40524060)
26. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA, Stem Cells 2006 24 2582 2591 10.1634/stemcells.2006-0228 16873762 (Pubitemid 44674320)
27. The therapeutic effect of human adult stem cells derived from adipose tissue in endotoxemic rat model. Shin S, Kim Y, Jeong S, Hong S, Kim I, Lee W, Choi S, Int J Med Sci 2013 10 8 18 10.7150/ijms.5385 23289000
28. Glomerular filtration rate and renal scintigraphy. Kerl ME, Cook CR, Clin Tech Small an P 2005 20 31 38 10.1053/j.ctsap.2004.12.005 (Pubitemid 40269821)
29. Use of plasma clearance of iohexol for estimating glomerular filtration rate in cats. Miyamoto K, Am J Vet Res 2001 62 572 575 10.2460/ajvr.2001.62.572 11327466 (Pubitemid 33605778)
30. Disposition of plasma creatinine in non-azotaemic and moderately azotaemic cats. Le Garreres A, Laroute V, De La Farge F, Boudet KG, Lefebvre HP, J Feline Med Surg 2007 9 89 96 10.1016/j.jfms.2006.08.003 17049290 (Pubitemid 46437994)
31. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease. Habenicht LM, Webb TL, Clauss LA, Dow SW, Quimby JM, J Feline Med Surg 2013 15 99 104 10.1177/1098612X12461007 22989558
32. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Gao J, Liu R, Wu J, Liu Z, Li J, Zhou J, Hao T, Wang Y, Du Z, Duan C, Wang C, Biomaterials 2012 33 3673 3681 10.1016/j.biomaterials.2012.01.061 22361096
33. Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney. Furuichi K, Shintani H, Sakai Y, Ochiya T, Matsushima K, Kaneko S, Wada T, Clin Exp Nephrol 2012 16 679 689 10.1007/s10157-012-0614-6 22398959
34. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Choi S, Park M, Kim J, Hwang S, Park S, Lee Y, Stem Cells Dev 2009 18 521 529 10.1089/scd.2008.0097 18647091
35. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. Togel F, Zhang P, Hu Z, Westenfelder C, J Cell Mol Med 2009 13 2109 2114 10.1111/j.1582-4934.2008.00641.x 19397783
36. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease. McTaggart SJ, Atkinson K, Nephrology (Carlton) 2007 12 44 52 10.1111/j.1440-1797.2006.00753.x
37. Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Martinello T, Bronzini I, Maccatrozzo L, Mollo A, Sampaolesi M, Mascarello F, Decaminada M, Patruno M, Res Vet Sci 2011 91 18 24 10.1016/j.rvsc.2010.07.024 20732703
38. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Ginis I, Grinblat B, Shirvan MH, Tissue Eng Part C Methods 2012 6 453 463
39. Are therapeutic human mesenchymal stromal cells compatible with human blood? Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen AM, Elgue G, Funke L, Hamad OA, Lonnies H, Magnusson PU, Sanchez J, Teramura Y, Nilsson-Ekdahl K, Ringden O, Korsgren O, Nilsson B, Le Blanc K, Stem Cells 2012 30 1565 1574 10.1002/stem.1111 22522999
40. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, Heilberg IP, Clin J Am Soc Nephrol 2008 3 348 354 10.2215/CJN.02870707 18235143